Anticancer Effects of Niclosamide in Human GlioblastomaAnja Wieland, Björn Scheffler, Daniel Trageser et al.|Clinical Cancer Research|2013Cited by 161
Targeting the Cytosolic Innate Immune Receptors RIG-I and MDA5 Effectively Counteracts Cancer Cell Heterogeneity in GlioblastomaMartin Glas, Björn Scheffler, Ulrich Herrlinger et al.|Stem Cells|2013Cited by 74
Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human GlioblastomaRoman Reinartz, Björn Scheffler, Shanshan Wang et al.|Clinical Cancer Research|2016Cited by 72
Drug repositioning of antiretroviral ritonavir for combinatorial therapy in glioblastomaLaurèl Rauschenbach, Björn Scheffler, Anja Wieland et al.|European Journal of Cancer|2020Cited by 22
A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in GlioblastomaSied Kebir, Björn Scheffler, Vivien Ullrich et al.|Clinical Cancer Research|2022Cited by 4